Small study reveals immune changes after hair loss drug
NCT ID NCT07645430
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 20 adults with severe alopecia areata (hair loss) to see how the drug baricitinib changes certain immune markers in the blood. Researchers measured levels of two proteins, interleukin-15 and interferon gamma, before and after six months of treatment. The goal was to understand how the drug works, not to test if it cures the condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of medicine, Benha University (Dermatology department)
Banhā, 13511, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill help teens regrow hair lost to alopecia?
- Can allergy and glaucoma drugs regrow hair when delivered by microneedling?
- Can a daily pill bring back hair in severe alopecia?
- Can Real-World data unlock better skin disease care?
- Can a daily pill regrow hair in alopecia areata? a trial seeks answers
- Blood test may reveal hidden clues to hair loss severity